Laserfiche WebLink
<br />I <br /> <br />I <br /> <br />I <br /> <br />D. Repayment Capability <br /> <br />I <br /> <br />Presented in Table-II is the Payout Schedule for both the Rehabilitation <br />and Enlargement alternatives. The revenues and expenses were presented in <br />Tables 9 and 10 and summarized in Table-II. The loan amortization portion of <br />the table is comprised of a CWCB advance for 40 years at 5%, plus a 10% of the <br />annual payment for the first 10 years for the Emergency Operation Fund. To <br />finance the remaining 50% of the project, it is assumed that 20 year revenue <br />bonds will be issued (see Section VII-C-4). The annual and accumulated sur- <br />plus or deficit for each alternative are presented in the last columms of the <br />Table-II. <br /> <br />I <br /> <br />I <br /> <br />I <br /> <br />I <br /> <br />For tee Rehabilitation alternative there is an accumulated deficit for the <br /> <br />I <br /> <br />years 1983, 1984, and 1985 in the amount of $133,500, $103,600, and $58,000, <br />respectively. This deficit is due to the initial costs exceeding the CWCB <br />advance and bond issue funds prior to receiving any i~come from the newly issued <br />taps. As the number of taps issued increases, an accumluated surplus results <br />beginning in 1986 ($3,400) through 2024 ($15,237,300). <br /> <br />I <br /> <br />I <br /> <br />For the Enlargement alternative, there is an accumulated deficit for the <br /> <br /> <br />years 1983 and 1984 in the amount of $201,800 and $63,900, respectively. This <br /> <br /> <br />deficit is also due to the initial costs exceeding the CWCB advance and bond <br /> <br /> <br />issue funds prior to receiving any income from the newly issued taps. However, <br /> <br /> <br />an accumulated surplus starts in 1985 ($106,500) and increases to $35,820,500. <br /> <br /> <br />in 2024 which is considerably larger than the Rehabilitation alternative. <br /> <br />I <br /> <br />I <br /> <br />I <br /> <br />E. Benefit/Cost Comparison <br /> <br />I <br /> <br />In addition to the comparison of annual revenues and expenses of Section <br />VII-D, a benefit/cost comparison has been made. The analysis consisted of <br />distributing the costs (those items of Table-9 plus loan ammortization) and <br />the revenues (Table-IO) and then computing the present worth of the various <br />components using an interest rate of 5%. A sample plotting for the Enlargement <br /> <br />I <br /> <br />I <br /> <br />I <br /> <br />I <br /> <br />-32- <br />